Nexgen to join WHO's R&D project for rabies antibody

Published: 2006-01-16 06:58:00
Updated: 2006-01-16 06:58:00
Nexgen, a plant genetic engineering venture company, announced on Jan. 10 about their participation in the WHO's project for the rabies antibody development by the use of plant as a part of "Pharma-Planta consortium" proceeded by EU.

The company said "Our molecular farming technology has been...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.